![Nicholas Simon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicholas Simon
Direktor/Vorstandsmitglied bei
The J. David Gladstone Institutes
Profil
Nicholas Simon founded Clarus Ventures LLC in 2005, where he worked as Managing Director from 2005 to 2018 and Collabra Pharma, Inc. in 2000, where he worked as Chief Executive Officer & Director in 2000.
Mr. Simon also currently works at Rinat Neuroscience Corp., as Director, Nuvelution Pharma, Inc., as Director, MPM BioVentures III GP LP, as General Partner from 2001, The California Academy of Sciences, as Trustee from 2019, The J.
David Gladstone Institutes, as Trustee & Member, and Blackstone Life Sciences Advisors LLC, as Operating Partner from 2018.
Mr. Simon also formerly worked at Poniard Pharmaceuticals, Inc., as Independent Director from 2006 to 2012, SangStat Medical Corp., as Director, Avanir Pharmaceuticals, Inc., as Director from 2008 to 2010, InterMune, Inc., as Director, Rigel Pharmaceuticals, Inc., as Director, QuatRx Pharmaceuticals Co., as Director, Genitope Corp., as Director, Barrier Therapeutics, Inc., as Director from 2003 to 2007, CoTherix, Inc., as Director from 2003 to 2007, Proacta, Inc., as Director, Achillion Pharmaceuticals, Inc., as Independent Director from 2011 to 2012, Verus Pharmaceuticals, Inc., as Director, Neosil, Inc., as Director, Lycera Corp., as Director, Biovitrum AB, as Director, ARYx Therapeutics, Inc., as Director, Genteric, Inc., as Director, Project Sage Oldco, Inc., as Lead Independent Director from 2015 to 2021, Pearl Therapeutics, Inc., as Director, Gritstone bio, Inc., as Independent Director from 2015 to 2021, Genentech, Inc., as Vice President-Business & Corporate Development from 1989 to 2000, XOMA Royalty Corp., as Principal, and MPM BioImpact LLC, as General Partner from 2001 to 2005.
Mr. Simon received his Masters Business Admin degree from Loyola University of Chicago and undergraduate degree from the University of Maryland.
Aktive Positionen von Nicholas Simon
| Unternehmen | Position | Beginn |
|---|---|---|
The J. David Gladstone Institutes
 The J. David Gladstone Institutes Miscellaneous Commercial ServicesCommercial Services Engages in conducting research in biotechnology | Direktor/Vorstandsmitglied | - |
MPM BioVentures III GP LP | Corporate Officer/Principal | 01.01.2001 |
The California Academy of Sciences
 The California Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a scientific and cultural institution | Direktor/Vorstandsmitglied | 25.09.2019 |
Rinat Neuroscience Corp.
 Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Direktor/Vorstandsmitglied | - |
Blackstone Life Sciences Advisors LLC
 Blackstone Life Sciences Advisors LLC Investment ManagersFinance Blackstone Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields on pharmaceutical, biotechnology and medical technology sectors. It provides financing for growth stage transactions. | Private Equity Investor | 01.12.2018 |
Ehemalige bekannte Positionen von Nicholas Simon
| Unternehmen | Position | Ende |
|---|---|---|
| PROJECT SAGE OLDCO, INC. | Vorsitzender | - |
| GRITSTONE BIO, INC. | Direktor/Vorstandsmitglied | 01.06.2021 |
SangStat Medical Corp.
 SangStat Medical Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic and monitoring products to improve the outcome of organ transplantation | Direktor/Vorstandsmitglied | 04.11.2019 |
Clarus Ventures LLC
 Clarus Ventures LLC Investment ManagersFinance Clarus Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of biopharmaceutical and medical technology. It participates in early stage capital transactions. Clarus Ventures acquired by Blackstone Inc on November 30, 2018. Clarus ventures will become Blackstone Life Sciences. | Gründer | 31.12.2018 |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Nicholas Simon
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
84
Beziehungen ersten Grades
33
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 33 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Poniard Pharmaceuticals, Inc.
 Poniard Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapeutic biopharmaceuticals, primarily for the treatment of cancer, cardiovascular and inflammatory diseases | Health Technology |
SangStat Medical Corp.
SangStat Medical Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic and monitoring products to improve the outcome of organ transplantation | Health Technology |
XOMA Royalty Corp.
 XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for the treatment of nervous system disorder | Health Technology |
InterMune, Inc.
 InterMune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Rigel Pharmaceuticals, Inc.
 Rigel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which discovers, develops and provides novel small-molecule drugs | Health Technology |
QuatRx Pharmaceuticals Co.
 QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Manufactures and develops therapeutic compounds | Health Technology |
MPM BioVentures III GP LP | |
Genitope Corp.
 Genitope Corp. BiotechnologyHealth Technology Develops immunotherapies for the treatment of cancer | Health Technology |
Barrier Therapeutics, Inc.
 Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products in the field of dermatology | Health Technology |
CoTherix, Inc.
 CoTherix, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products | Health Technology |
Proacta, Inc.
 Proacta, Inc. BiotechnologyHealth Technology Develops drugs to treat cancer | Health Technology |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments for infectious diseases | Health Technology |
Verus Pharmaceuticals, Inc.
 Verus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pediatric-oriented pharmaceutical products | Health Technology |
Neosil, Inc.
 Neosil, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Lycera Corp.
 Lycera Corp. Pharmaceuticals: MajorHealth Technology Develops novel oral medicines for treating autoimmune diseases and cancer | Health Technology |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Commercial Services |
ARYx Therapeutics, Inc.
 ARYx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Loyola University of Chicago
 Loyola University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genteric, Inc.
 Genteric, Inc. Pharmaceuticals: MajorHealth Technology Develops revolutionary therapeutic protein delivery technology | Health Technology |
Rinat Neuroscience Corp.
Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Health Technology |
Clarus Ventures LLC
Clarus Ventures LLC Investment ManagersFinance Clarus Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of biopharmaceutical and medical technology. It participates in early stage capital transactions. Clarus Ventures acquired by Blackstone Inc on November 30, 2018. Clarus ventures will become Blackstone Life Sciences. | Finance |
The California Academy of Sciences
The California Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a scientific and cultural institution | Commercial Services |
Project Sage Oldco, Inc.
 Project Sage Oldco, Inc. Medical SpecialtiesHealth Technology Develops and sells medical aesthetics products | Health Technology |
The J. David Gladstone Institutes
The J. David Gladstone Institutes Miscellaneous Commercial ServicesCommercial Services Engages in conducting research in biotechnology | Commercial Services |
Pearl Therapeutics, Inc.
 Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of chronic respiratory diseases | Health Technology |
Collabra Pharma, Inc. | |
Nuvelution Pharma, Inc.
 Nuvelution Pharma, Inc. BiotechnologyHealth Technology Provides solutions for R&D companies in the pharmaceutical and biotech industries | Health Technology |
Gritstone bio, Inc.
 Gritstone bio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer | Health Technology |
Blackstone Life Sciences Advisors LLC
Blackstone Life Sciences Advisors LLC Investment ManagersFinance Blackstone Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields on pharmaceutical, biotechnology and medical technology sectors. It provides financing for growth stage transactions. | Finance |
